Protecting and improving the health of communities through promotion of healthy lifestyles, research, and detection and control of infectious diseases.
During this exclusive on-the-record briefing for reporters, Robert M. Califf, M.D., Commissioner of Food and Drugs for the U.S. Food and Drug Administration, participated in a fireside chat with Sarah J. Dash, President and CEO of the Alliance for Health Policy, and respond to audience questions.
During this session, panelists provided an overview of the role of the FDA particularly focusing on the approval process required to bring new medical products to market.
This event explored health policy milestones from the past year and their potential impact on 2022. Panelists offered a high-level analysis of the policies that Congress and the administration have pursued to date, potential implementation opportunities and challenges, as well as current health-related court cases.
In this briefing, experts overviewed demographics of the Native American population in the United States as well as the current policy and regulatory landscape that guides and directs Native American health care infrastructure.
In this briefing, experts overviewed what comprises the field of environmental health and its corresponding policy, outlined the major players at the state and federal level, and highlighted immediate policy opportunities. Panelists also discussed how health disparities and inequities are tied to environmental factors and offered thoughts on how to close policy gaps.
In this briefing, experts overviewed the specific health and access challenges faced by people experiencing homelessness. Panelists also offered insights on how to deliver effective health care to this population, with a specific focus on barriers to access and potential policy strategies to alleviate these barriers.
This 3-hour summit convened and informed health policy and oncology research communities about critical issues related to patient-centered cancer care and offered lessons, strategies, and policy approaches for the short and long term.
During this exclusive on-the-record briefing for reporters, Admiral Rachel L. Levine, M.D., Assistant Secretary for Health at the U.S. Department of Health and Human Services, provided some opening remarks and responded to audience questions.
Elizabeth Fowler, J.D., Ph.D., director of the Center for Medicare and Medicaid Innovation (CMMI) and deputy administrator of the Centers for Medicare and Medicaid Services at the U.S. Department of Health and Human Services, provided some opening remarks and responded to audience questions.
This briefing will explore how the U.S. has fared during the COVID-19 pandemic to-date and highlight key takeaways learned in the U.S. response, as well as important lessons learned from peer countries.
In this briefing, experts discussed how flu and the COVID-19 pandemic have intersected over the past 18 months and why we should also prioritize flu preparedness policy. Panelists also highlighted available federal policy levers and discuss policy strategies to improve our flu response.
This event outlined the latest science on nicotine initiation, addiction, and cessation, the use of flavorings in tobacco products, as well as the disparate impact of menthol tobacco products on various populations, especially communities of color.
This briefing reviewed the opportunities and challenges that have arisen for first line providers and current integration efforts to ensure equitable preventative care for the American public. Experts addressed the role of data sharing, payment systems, and workforce provisions.
There is no excerpt because this is a protected post.
Expert panelists delved into where America stands in public health a year into the COVID-19 pandemic. They discussed how the COVID-19 pandemic has shaped clinical care, state preparedness, and the individual consumer experience and shed light on promising frameworks and infrastructures being built today to protect Americans from a major public health emergency tomorrow.
Attendees learned the challenges and opportunities states face in safe and timely vaccine deployment and supply management, plans states are executing to ensure equitable vaccine distribution, and plans states are executing to ensure equitable vaccine distribution along the way.
Dr. Stephen Hahn addressed the role of the U.S. Food and Drug Administration in the COVID-19 response and best practices and lessons learned from the emergency response to date.
This briefing explored how our supply chain must respond to manufacture millions of doses and then swiftly deliver them to administration sites. Panelists also illustrated the steps these stakeholders might take in the first 48 hours after an Emergency Use Authorization is approved.
This briefing provided an overview of how census data is collected, analyzed, and utilized, with a particular focus on how this process impacts health policy and public health.
During this webinar, panelists addressed the following learning goals: the short- and long-term impact of COVID-19 on mental health and well being; evidence-based interventions and promising technology to reach people where they are and improve outcomes; and sustainable solutions to address the mental health impact of COVID-19 and advance access to behavioral health services beyond the pandemic.
COVID-19 Webinar Series Session 18 – Health Inequities: Addressing the Disease Burden in Black, Indigenous, and People of Color Communities
During this webinar, speakers examined the following learning goals: the disproportionate impact of COVID-19 on Black, Indigenous, and People of Color communities in the U.S.; the drivers of these disparities; and short- and long-term policy options to advance equity and improve COVID-19 outcomes.
This webinar will explain the role of Medicaid in the COVID-19 pandemic. Panelists will discuss financing challenges of the Medicaid program—the nation’s health care safety net—as more people become eligible for Medicaid coverage and demand for health services shifts.
During this webinar, panelists discussed the recent evolution of our primary care system and outlined policy levers to bolster our nation’s primary care infrastructure.
During this webinar, panelists explored the impact of the pandemic on different facets of the drug supply chain and discussed policy options to strengthen the system.
COVID-19 Webinar Series Session 14 – Lessons from Home and Abroad: Implementing a Contact Tracing Strategy
During this webinar, panelists discussed case studies from abroad and best practices as policymakers look to implement a contact tracing strategy in the United States.
During this webinar, panelists discussed policy options to support high quality care for nursing home residents during the COVID-19 pandemic.
COVID-19 Webinar Series Session 12 – From Data to Decisions: Mobilizing a Surveillance Infrastructure
During this webinar, panelists will explore options policymakers can pursue to strengthen our surveillance infrastructure as we move from mitigation to containment of the COVID-19 pandemic.
In this webinar, panelists will discuss the unique challenges that face rural health systems and the strategies they are employing during the emergency response. They will also highlight current or future legislative and administrative policy solutions.